MARKET

VKTXW

VIKING THERAPEUT
VKTXW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-8.4559
-
1.378
-
VIKING THERAPEUTICS INC <VKTX.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $83 FROM $75
Reuters · 3d ago
U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys
Reuters · 3d ago
Viking Therapeutics shareholders elect Singleton, Rouan as Class II directors
PUBT · 3d ago
Viking Therapeutics to present at William Blair Growth Stock Conference
PUBT · 05/21 11:06
Viking says oral VK2735 cuts weight up to 12.2% in Phase 2 trial
PUBT · 05/12 11:10
VIKING THERAPEUTICS PRESENTS DATA FROM ITS 13-WEEK PHASE 2 VENTURE-ORAL DOSING TRIAL OF VK2735 AT EUROPEAN CONGRESS ON OBESITY (ECO) 2026
Reuters · 05/12 11:05
Viking Therapeutics presents Phase 2 oral VK2735 weight-loss data at ECO 2026
PUBT · 05/05 11:14
Ligand, Viking dispute TR-Beta program termination under license agreement
PUBT · 04/30 21:38
More

Webull offers VIKING THERAPEUT stock information, including NASDAQ: VKTXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VKTXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VKTXW stock methods without spending real money on the virtual paper trading platform.